Camtek director reports initial share and option holdings
Camtek Ltd director Ben Arie Mordechay filed an initial ownership report showing his equity position in the company.
Rhea-AI Filing Summary
Camtek Ltd director Ben Arie Mordechay filed an initial ownership report showing his equity position in the company. The filing lists fully vested stock options over 880 ordinary shares at an exercise price of $63.51, 1,509 shares at $81.28, and 1,095 shares at $59.76, with expirations between 2030 and 2032. It also shows direct holdings of ordinary shares, including 1,009 shares and 628 shares. Footnotes explain that some shares were issued upon vesting of restricted stock units and that certain options and RSUs will vest on the date of Camtek’s 2026 annual meeting of shareholders, subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Ben Arie Mordechay
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 3,484 contracts (Direct);
Ordinary Shares — 1,637 shares (Direct)
Footnotes (4)
- F1. These shares were issued upon vesting of previously granted restricted stock units ("RSUs"), which each represent a contingent right to receive one ordinary share of Camtek Ltd. (the "Company").
- F2. The Reporting Person was granted RSUs, which each represent a contingent right to receive one ordinary share of the Company. The RSUs will vest on the date of the Company's 2026 annual meeting of shareholders, subject to continued service through the vesting date.
- F3. The Stock Options are Fully vested and immediately exercisable
- F4. The options will vest on the date of the Company's 2026 annual meeting of shareholders, subject to continued service through the vesting date.
Key Figures
Option exercise price: $63.51 per share
Option exercise price: $81.28 per share
Option exercise price: $59.76 per share
+3 more
6 metrics
Option exercise price
$63.51 per share
Stock option over 880 ordinary shares, expiration December 21, 2030
Option exercise price
$81.28 per share
Stock option over 1,509 ordinary shares, expiration September 25, 2031
Option exercise price
$59.76 per share
Stock option over 1,095 ordinary shares, expiration April 29, 2032
Underlying option shares
880 ordinary shares
Stock option (Right to Buy), fully vested and exercisable per footnote
Direct ordinary shares
1,009 shares
Direct holding of Camtek ordinary shares following reported holding entry
Direct ordinary shares
628 shares
Additional direct holding of Camtek ordinary shares following reported holding entry
Key Terms
Stock Option (Right to Buy), Ordinary Shares, restricted stock units ("RSUs"), exercise price, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)" tied to ordinary shares"
restricted stock units ("RSUs") financial
"These shares were issued upon vesting of previously granted restricted stock units ("RSUs")"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
exercise price financial
"conversion_or_exercise_price fields such as "63.5100" and "81.2800""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Camtek (CAMT) director Ben Arie Mordechay report on his Form 3?
Ben Arie Mordechay reports his initial ownership in Camtek, including stock options over specific numbers of ordinary shares and direct holdings of ordinary shares. The filing details exercise prices, expiration dates, and vesting conditions tied to Camtek’s 2026 annual meeting of shareholders.
What stock options does Ben Arie Mordechay hold in Camtek (CAMT)?
He holds stock options over 880 ordinary shares at $63.51, 1,509 shares at $81.28, and 1,095 shares at $59.76. These options are either fully vested and immediately exercisable or scheduled to vest subject to continued service through Camtek’s 2026 annual meeting.
How are restricted stock units (RSUs) described in the Camtek (CAMT) Form 3 footnotes?
Footnotes state that certain shares were issued upon vesting of previously granted RSUs, each representing a contingent right to receive one ordinary share. Additional RSUs are scheduled to vest on Camtek’s 2026 annual meeting date, conditioned on the reporting person’s continued service.
When do Ben Arie Mordechay’s Camtek (CAMT) stock options expire?
The disclosed stock options expire on dates between 2030 and 2032. One grant expires on December 21, 2030, another on September 25, 2031, and a third on April 29, 2032, defining long-dated option terms linked to Camtek ordinary shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
